Weekly Updates

Aspergillosis research: this week’s update

This week’s papers look at…

The Thursday Sessions online aspergillosis support meeting, every Thursday at 10 am UK time, illustrated with three people joining from home.

Thursday Sessions: When symptoms aren’t believed: being heard when tests don’t explain everything

Patient and clinician discussing aspergillosis research, with illustrated lungs and fungal spores

This Week in Aspergillosis Research: Dupilumab and ABPA

Clinician reviewing lung research data in an illustration about new findings in aspergillosis care.

Research update: new ABPA treatment results, and lessons from viral infections

Medical illustration of lungs and Aspergillus highlighting new research into the relationship between COPD and aspergillosis.

Weekly Aspergillosis Research Update – 24 August 2026

New aspergillosis research into urine testing for invasive aspergillosis, Aspergillus IgG testing in CPA and selection of azole antifungal treatment.

New aspergillosis research update: urine testing, CPA antibodies and choosing antifungal treatment

Clinician reviewing CT scans showing chronic pulmonary aspergillosis, mucus plugging and a lung cavity

Aspergillosis Weekly Research Update: New Clues About Diagnosis, Treatment and Resistance

Aspergillosis Research Update: Corticosteroid Risks, Azole Resistance and Immune Recovery

Illustration of inhaled itraconazole being delivered into the lungs as a potential treatment for ABPA

Aspergillosis Weekly Research Update

Aspergillosis research update infographic summarising July 2026 studies on invasive aspergillosis, isavuconazole, macrophages and tuberculosis.

Aspergillosis Research Update: ICU Infections, Immune Defences and Antifungal Treatment